Mehler-Wex C, Warnke A
Klinik u Poliklinik für Kinder- u Jugendpsychiatrie u Psychotherapie, Würzburg.
MMW Fortschr Med. 2006 Mar 9;148(10):37-9. doi: 10.1007/BF03364589.
In the ICD-10 classification, the body dysmorphophobic (dysmorphic) disorder is subsumed under the code for somatoform or hypochondriacal disorders (F45.2). To the fore is an excessive preoccupation with an imagined, but not objectifiable, bodily defect, usually affecting a part of the body that is either exposed or considered to be of importance for the patient's attractiveness. In many cases, the patient insistently demands surgical correction. During the further course of the condition, depression, social phobia, obsessive-compulsive and self-destructive behavior may develop. The condition usually begins early in the patient's life, and the lifetime prevalence is estimated to be 5%. Since an involvement of the serotonergic system is assumed, selective serotonin reuptake inhibitors are considered to be the medication of first choice. Surgical interventions do not lead to remission but simply to a transference of symptoms. Referral to a psychiatric specialist with the aim of clarifying the diagnosis is indicated.
在国际疾病分类第十版（ICD - 10）中，躯体变形恐惧症（畸形）障碍被归入躯体形式或疑病症（F45.2）编码之下。其主要特征是过度关注一种想象中的、但无法客观确定的身体缺陷，通常影响身体的某个暴露部位或患者认为对自身吸引力很重要的部位。在许多情况下，患者会坚持要求手术矫正。在病情的进一步发展过程中，可能会出现抑郁、社交恐惧症、强迫行为和自我毁灭行为。这种疾病通常在患者早年发病，终生患病率估计为5%。由于假定涉及血清素能系统，选择性血清素再摄取抑制剂被认为是首选药物。手术干预不会导致病情缓解，只会使症状转移。建议转诊至精神科专科医生处，以明确诊断。
